Company / Total Assets
Annovis Bio, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$21.1M
FY2025
5-year range
$10.2M / $46.0M
FY2021-FY2025
Trend
+51.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $10M to $21M over the past 2 years.
Based on SEC 10-K filings.
$21M in FY2025 with a 5-year CAGR of +21.0%.
Improved from $10M to $21M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -16.4%
- 5-Year CAGR
- +21.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +21.0%, indicating consistent growth.
- In FY2025, total assets increased 51.4% year-over-year.
- Peak total assets was recorded in FY2021.
- Lowest total assets in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.28 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $21.1M | +51.4% |
| FY2024 | $13.9M | +36.4% |
| FY2023 | $10.2M | -71.7% |
| FY2022 | $36.0M | -21.7% |
| FY2021 | $46.0M | +466.6% |
| FY2020 | $8.1M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026